| 10851061 |
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use |
Dana T. Aftab, Nathan Guz, Stephen Lau, Noel Hamill, Tracy Carol Walker +2 more |
2020-12-01 |
| 10813936 |
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]pyrimidin-3-YL)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate |
Alisha B. Arrigo, Derrick Juengst |
2020-10-27 |
| 10799505 |
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate |
Alisha B. Arrigo, Derrick Juengst |
2020-10-13 |
| 10676515 |
Multimodal trail molecules expressed in T cells |
— |
2020-06-09 |
| 10633636 |
Oncolytic virus therapy for resistant tumors |
Kaoru Tamura, Hiroaki Wakimoto |
2020-04-28 |
| 10548888 |
C-Met modulator pharmaceutical compositions |
Jo Ann Wilson |
2020-02-04 |
| 10543206 |
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
Jo Ann Wilson |
2020-01-28 |
